Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study

Dopamine and serotonin have been indirectly found to be associated with generalized anxiety disorder (GAD). The aims of this study were to examine the availabilities of the striatal dopamine transporter (DAT) and the midbrain serotonin transporter (SERT) in patients with GAD. 12 patients with GAD and 12 sex-matched, age-matched, and smoking status-matched healthy controls were recruited. The availabilities of DAT and SERT were approximated using single-photon emission computed tomography, with [99mTc]TRODAT-1 and [123I]ADAM as the ligands. There were several missing data for six participants with GAD in the ADAM study because of a lack of the radioligand at the time of the experiment. The DAT availability in the striatum was significantly lower in the patients with GAD than in the healthy controls. However, the SERT availability did not differ between the two groups. The results with respect to the striatal DAT level suggested a potential role in the pathophysiology of GAD.

[1]  Wolfgang Wadsak,et al.  Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder , 2007, Biological Psychiatry.

[2]  C. Antke,et al.  Cortical GABA, Striatal Dopamine and Midbrain Serotonin as the Key Players in Compulsive and Anxiety Disorders - Results from In Vivo Imaging Studies , 2010, Reviews in the neurosciences.

[3]  D. Nutt,et al.  Neuroimaging of serotonin system in anxiety disorders. , 2012, Current pharmaceutical design.

[4]  W. Hwang,et al.  Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  I. Lee,et al.  Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder – a preliminary two-ligand SPECT study , 2014, European Psychiatry.

[6]  S. Orsillo,et al.  Investigating cognitive flexibility as a potential mechanism of mindfulness in Generalized Anxiety Disorder. , 2014, Journal of behavior therapy and experimental psychiatry.

[7]  M. Liebowitz,et al.  Low dopamine D(2) receptor binding potential in social phobia. , 2000, The American journal of psychiatry.

[8]  J. Tiihonen,et al.  Seasonal variation in the occurrence of homicide in Finland. , 1997, The American journal of psychiatry.

[9]  Nan-Tsing Chiu,et al.  The relationships between daily life events and the availabilities of serotonin transporters and dopamine transporters in healthy volunteers—A dual-isotope SPECT study , 2009, NeuroImage.

[10]  T. Su,et al.  Imaging the serotonin transporter using 123I-ADAM in the human brain , 2009, Psychiatry Research: Neuroimaging.

[11]  F. Graeff,et al.  The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. , 2010, Central nervous system agents in medicinal chemistry.

[12]  K. Audenaert,et al.  Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder , 2012, Psychiatry Research: Neuroimaging.

[13]  R. V. Van Heertum,et al.  Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [11C]McN 5652 , 2002, Psychopharmacology.

[14]  M. Liebowitz,et al.  Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder , 2009, Depression and anxiety.

[15]  K. Erlandsson,et al.  Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  J. Tiihonen,et al.  Dopamine reuptake site densities in patients with social phobia. , 1997, The American journal of psychiatry.

[17]  C. Rück,et al.  Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder , 2012, Translational Psychiatry.

[18]  H. Westenberg,et al.  Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication–Naïve Patients with Generalized Social Anxiety Disorder Shown by 123I-β-(4-Iodophenyl)-Tropane SPECT , 2008, Journal of Nuclear Medicine.

[19]  R. Pitman,et al.  Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [99mTc]TRODAT-1 , 2012, Psychopharmacology.

[20]  D. Nutt,et al.  Dopamine transporter binding in females with panic disorder may vary with clinical status. , 2010, Journal of psychiatric research.

[21]  K. Chen,et al.  Availability of dopamine and serotonin transporters in opioid-dependent users—a two-isotope SPECT study , 2011, Psychopharmacology.

[22]  Yuan-Hwa Chou,et al.  Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers — A SPECT study , 2011, NeuroImage.

[23]  Y. Kuang Yang,et al.  The adjustment to illness in patients with generalized anxiety disorder is poorer than that in patients with end-stage renal disease. , 2004, Journal of psychosomatic research.

[24]  R. Rahe.  Epidemiological Studies of Life Change and Illness , 1975, International journal of psychiatry in medicine.

[25]  Thomas Villmann,et al.  Serotonin and dopamine transporter imaging in patients with obsessive–compulsive disorder , 2005, Psychiatry Research: Neuroimaging.

[26]  H. Eriksson,et al.  Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study , 2012, International clinical psychopharmacology.